Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy.
Mario Lima-FontesMariana Leuzinger-DiasRicardo Barros-PereiraVítor FernandesManuel FalcãoFernando Falcão-ReisAmândio Rocha-SousaPedro Alves-FariaPublished in: Ophthalmology and therapy (2022)
FAc implant can be considered a therapeutic alternative in PCME refractory to other therapies in vitrectomized eyes, reducing the need for repeated treatments.